Literature DB >> 11286759

Microsatellite instability as a tool for the classification of gastric cancer.

A J Simpson1, O L Caballero, S D Pena.   

Abstract

Microsatellite instability (MSI) is a common feature of gastric cancers that reflects underlying mismatch-repair deficiency in the tumor, caused most frequently by methylation of the hMLH1 promoter. Tumors with MSI have been found to inactivate certain target genes by permitting an increased frequency of mutations in mononucleotide runs in their coding regions. Gastric tumors with MSI have a distinct clinicopathological profile with a relatively good prognosis. Using the simple and robust methodologies available, MSI detection in gastrointestinal tumors promises to be one of the first widely used molecular prognostic tests for human cancer. Here, we review the molecular context of this exciting prospect with respect to one of the world's most prevalent cancers, that of the stomach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286759     DOI: 10.1016/s1471-4914(01)01916-5

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  13 in total

1.  Detection of microsatellite instability in gastric cancer and dysplasia tissues.

Authors:  Bing Li; Hong-Yi Liu; Shao-Hua Guo; Peng Sun; Fang-Ming Gong; Bao-Qing Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 3.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

4.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 5.  Genomic and genetic alterations influence the progression of gastric cancer.

Authors:  Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 6.  Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.

Authors:  Scott M Weissman; Cecelia Bellcross; Christina Chimera Bittner; Mary E Freivogel; Joy Larsen Haidle; Pardeep Kaurah; Anna Leininger; Selvi Palaniappan; Kelle Steenblock; Thuy M Vu; Molly S Daniels
Journal:  J Genet Couns       Date:  2010-10-08       Impact factor: 2.537

Review 7.  Helicobacter pylori persistence: biology and disease.

Authors:  Martin J Blaser; John C Atherton
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 8.  Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

9.  Case report: mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance.

Authors:  Kuo-Hsing Chen; Chang-Tsu Yuan; Li-Hui Tseng; Chia-Tung Shun; Kun-Huei Yeh
Journal:  J Hematol Oncol       Date:  2016-03-24       Impact factor: 17.388

Review 10.  Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.

Authors:  Dustin J Flanagan; Elizabeth Vincan; Toby J Phesse
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.